Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	FHA	RNF8 SLMAP	1.32e-03	28	36	2	SM00240
Domain	FHA_DOMAIN	RNF8 SLMAP	1.62e-03	31	36	2	PS50006
Domain	FHA	RNF8 SLMAP	1.62e-03	31	36	2	PF00498
Domain	FHA_dom	RNF8 SLMAP	2.18e-03	36	36	2	IPR000253
Domain	-	RNF8 SLMAP	2.18e-03	36	36	2	2.60.200.20
Domain	-	ZC3H8 ZC3H15	2.69e-03	40	36	2	4.10.1000.10
Domain	ZnF_C3H1	ZC3H8 ZC3H15	3.85e-03	48	36	2	SM00356
Domain	zf-CCCH	ZC3H8 ZC3H15	4.01e-03	49	36	2	PF00642
Domain	SMAD_FHA_domain	RNF8 SLMAP	4.51e-03	52	36	2	IPR008984
Domain	Znf_CCCH	ZC3H8 ZC3H15	5.58e-03	58	36	2	IPR000571
Domain	ZF_C3H1	ZC3H8 ZC3H15	5.58e-03	58	36	2	PS50103
Domain	IQ	MYO3A SCN4A	8.26e-03	71	36	2	PF00612
Domain	IQ	MYO3A SCN4A	1.06e-02	81	36	2	SM00015
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	LARS1 GIGYF2 PUM3 HADHA RRBP1 ZC3H15 PCLO SLC27A4 PRDM2 HNRNPU DNMT1	1.68e-07	1425	37	11	30948266
Pubmed	A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer.	H1-6 GIGYF2 LIMA1 HADHA RRBP1 HNRNPU	5.51e-07	286	37	6	32041737
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	H1-6 HADHA RRBP1 ZSCAN30 ZC3H8 MORF4L1 SLC27A4 PRDM2 HNRNPU DNMT1	6.83e-07	1294	37	10	30804502
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	LIMA1 HADHA RRBP1 ZC3H15 SLC27A4 HNRNPU DNMT1	7.14e-07	486	37	7	30940648
Pubmed	Human transcription factor protein interaction networks.	LARS1 LRP2 GIGYF2 PUM3 ZFHX3 LIMA1 USP46 HADHA MORF4L1 PRDM2	1.68e-06	1429	37	10	35140242
Pubmed	CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity.	LRP2 LIMA1 HADHA RRBP1 SLC27A4 HNRNPU	4.93e-06	418	37	6	35338135
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	LARS1 PUM3 LIMA1 HADHA RRBP1 ZC3H15 HNRNPU DNMT1 SLMAP	5.10e-06	1257	37	9	36526897
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	LARS1 LIMA1 HADHA RRBP1 ZC3H15 PCID2 MORF4L1 HNRNPU DNMT1	6.57e-06	1297	37	9	33545068
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	PARP4 HADHA RRBP1 ZC3H8 ZC3H15 MORF4L1 HNRNPU DNMT1	6.75e-06	971	37	8	33306668
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	GIGYF2 LIMA1 HADHA RRBP1 HNRNPU	1.04e-05	274	37	5	34244482
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	H1-6 LIMA1 HADHA RRBP1 PCID2 PCLO SLC27A4 HNRNPU SCN4A	1.53e-05	1442	37	9	35575683
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	LARS1 PUM3 HADHA ZC3H15 MORF4L1 PRDM2 HNRNPU DNMT1	1.70e-05	1103	37	8	34189442
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	LARS1 AP1M2 ZFHX3 HADHA RRBP1 PCLO HNRNPU	1.98e-05	807	37	7	30575818
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	GIGYF2 LIMA1 RRBP1 ZC3H15 PCID2 SLMAP	2.79e-05	568	37	6	37774976
Pubmed	Acsl1 is essential for skin barrier function through the activation of linoleic acid and biosynthesis of ω-O-acylceramide in mice.	ELOVL4 SLC27A4	3.95e-05	9	37	2	34813948
Pubmed	Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins.	GIGYF2 LIMA1 HADHA DNMT1	4.95e-05	190	37	4	15161933
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	LARS1 GIGYF2 LIMA1 RRBP1 ZC3H15 HNRNPU DNMT1	5.02e-05	934	37	7	33916271
Pubmed	A protein interaction landscape of breast cancer.	PUM3 HADHA RRBP1 ZC3H15 MORF4L1 SLC27A4	5.15e-05	634	37	6	34591612
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	GIGYF2 HADHA RRBP1 PCID2 PCLO HNRNPU	5.38e-05	639	37	6	23443559
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	GIGYF2 PARP4 RRBP1 SLC27A4 HNRNPU DNMT1	5.91e-05	650	37	6	38777146
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	LARS1 GIGYF2 PUM3 HADHA RRBP1 HNRNPU	6.17e-05	655	37	6	35819319
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	PUM3 HADHA ZC3H8 MORF4L1 SLC27A4 HNRNPU DNMT1	7.19e-05	989	37	7	36424410
Pubmed	Chfr and RNF8 synergistically regulate ATM activation.	RNF8 MORF4L1	7.22e-05	12	37	2	21706008
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	LARS1 PUM3 HADHA RRBP1 PCID2 SLC27A4 HNRNPU DNMT1	7.24e-05	1353	37	8	29467282
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	LARS1 GIGYF2 PUM3 LIMA1 HADHA RRBP1 HNRNPU	8.94e-05	1024	37	7	24711643
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	LARS1 GIGYF2 HADHA RRBP1 ZC3H15 HNRNPU	9.46e-05	708	37	6	39231216
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	H1-6 RRBP1 ZC3H15 PCID2 HNRNPU DNMT1	9.68e-05	711	37	6	33022573
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	LARS1 GIGYF2 HADHA RRBP1 ZC3H15 MORF4L1 HNRNPU DNMT1	9.90e-05	1415	37	8	28515276
Pubmed	FANCB is essential in the male germline and regulates H3K9 methylation on the sex chromosomes during meiosis.	RNF8 H1-6	9.94e-05	14	37	2	26123487
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	GIGYF2 PARP4 HADHA RRBP1 RBMS3 ZC3H15	1.07e-04	724	37	6	36232890
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	LARS1 GIGYF2 HADHA RRBP1 SLC27A4 HNRNPU	1.08e-04	725	37	6	27025967
Pubmed	Loss of inherited genomic imprints in mice leads to severe disruption in placental lipid metabolism.	SLC27A4 DNMT1	1.15e-04	15	37	2	25662615
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	LRP2 PARP4 HADHA PCLO PRDM2 HNRNPU	1.17e-04	736	37	6	29676528
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	LARS1 PUM3 RRBP1 PCID2 HNRNPU DNMT1	1.38e-04	759	37	6	35915203
Pubmed	Proliferating cell nuclear antigen (PCNA)-associated KIAA0101/PAF15 protein is a cell cycle-regulated anaphase-promoting complex/cyclosome substrate.	RRBP1 DNMT1	1.48e-04	17	37	2	21628590
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	GIGYF2 MYO3A LIMA1 RRBP1 PRDM2 DNMT1	1.54e-04	774	37	6	15302935
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	GIGYF2 LIMA1 RRBP1 ZC3H15	1.56e-04	256	37	4	33397691
Pubmed	UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.	GIGYF2 LIMA1 HADHA SLMAP	1.84e-04	267	37	4	33417871
Pubmed	PNPLA1 defects in patients with autosomal recessive congenital ichthyosis and KO mice sustain PNPLA1 irreplaceable function in epidermal omega-O-acylceramide synthesis and skin permeability barrier.	ELOVL4 SLC27A4	1.86e-04	19	37	2	28369476
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	LARS1 H1-6 HADHA RBMS3 ZC3H8 ZC3H15 HNRNPU	1.86e-04	1153	37	7	29845934
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	GIGYF2 PUM3 RRBP1 ZC3H8 ZC3H15 HNRNPU	1.93e-04	807	37	6	22681889
Pubmed	KAP1 Recruitment of the 7SK snRNP Complex to Promoters Enables Transcription Elongation by RNA Polymerase II.	LARS1 PUM3 ZC3H8 HNRNPU	2.23e-04	281	37	4	26725010
Pubmed	A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis.	LARS1 LIMA1 HADHA	2.72e-04	118	37	3	27377895
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	LARS1 GIGYF2 LIMA1 RRBP1 HNRNPU	2.81e-04	551	37	5	34728620
Pubmed	Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1.	H1-6 HNRNPU	2.99e-04	24	37	2	31476572
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	LARS1 LIMA1 KANK1 HADHA RRBP1 PCID2 HNRNPU	3.00e-04	1247	37	7	27684187
Pubmed	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.	LARS1 LIMA1 HADHA HNRNPU	3.32e-04	312	37	4	37120454
Pubmed	Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells.	LARS1 ZNF706 MORF4L1 SLMAP	3.53e-04	317	37	4	11042152
Pubmed	TNRC6 proteins modulate hepatitis C virus replication by spatially regulating the binding of miR-122/Ago2 complexes to viral RNA.	HADHA RRBP1 MORF4L1 HNRNPU	3.53e-04	317	37	4	30997501
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	LARS1 HADHA RRBP1 PCID2 MORF4L1 SLC27A4 SLMAP	3.58e-04	1284	37	7	17353931
Pubmed	SCML2 establishes the male germline epigenome through regulation of histone H2A ubiquitination.	RNF8 H1-6	3.80e-04	27	37	2	25703348
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	LARS1 GIGYF2 RBMS3 HNRNPU DNMT1 SLMAP	4.00e-04	925	37	6	28986522
Pubmed	ATDC (Ataxia Telangiectasia Group D Complementing) Promotes Radioresistance through an Interaction with the RNF8 Ubiquitin Ligase.	RNF8 HNRNPU	4.09e-04	28	37	2	26381412
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	LARS1 H1-6 HADHA RRBP1 PCID2 HNRNPU DNMT1	4.19e-04	1318	37	7	30463901
Pubmed	Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN.	LARS1 LIMA1 RRBP1 HNRNPU	4.30e-04	334	37	4	30425250
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	LARS1 HADHA RRBP1 ZC3H8 ZC3H15 MORF4L1 HNRNPU	4.53e-04	1335	37	7	29229926
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	LARS1 GIGYF2 HADHA RRBP1 HNRNPU	4.64e-04	615	37	5	31048545
Pubmed	Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP.	RRBP1 HNRNPU	4.70e-04	30	37	2	22963397
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	GIGYF2 PUM3 RRBP1 ZC3H15 HNRNPU DNMT1	4.71e-04	954	37	6	36373674
Pubmed	BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs.	HNRNPU DNMT1	5.02e-04	31	37	2	23086144
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	LARS1 GIGYF2 ZC3H15 HNRNPU DNMT1	5.60e-04	641	37	5	36057605
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	LIMA1 RRBP1 HNRNPU SLMAP	5.69e-04	360	37	4	33111431
Pubmed	Identification of the BRD1 interaction network and its impact on mental disorder risk.	ZC3H15 DNMT1	6.41e-04	35	37	2	27142060
Pubmed	DSSylation, a novel protein modification targets proteins induced by oxidative stress, and facilitates their degradation in cells.	PCID2 HNRNPU	6.41e-04	35	37	2	24515614
Pubmed	Protein interaction profiling of the p97 adaptor UBXD1 points to a role for the complex in modulating ERGIC-53 trafficking.	LIMA1 HNRNPU	6.41e-04	35	37	2	22337587
Pubmed	Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2.	KANK1 OXR1 SLMAP	6.74e-04	161	37	3	32572027
Pubmed	RBP2 is an MRG15 complex component and down-regulates intragenic histone H3 lysine 4 methylation.	MORF4L1 HNRNPU	6.78e-04	36	37	2	17573780
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	LARS1 LIMA1 HADHA RRBP1 OXR1 PCLO HNRNPU	6.85e-04	1431	37	7	37142655
Pubmed	Human variation in alcohol response is influenced by variation in neuronal signaling genes.	ZFHX3 FEZ2 PCLO	8.02e-04	171	37	3	20201926
Pubmed	Beads-free protein immunoprecipitation for a mass spectrometry-based interactome and posttranslational modifications analysis.	PUM3 RRBP1 HNRNPU	8.16e-04	172	37	3	26336360
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	HADHA PCLO PRDM2 DNMT1	8.28e-04	398	37	4	35016035
Pubmed	Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation.	RRBP1 HNRNPU	8.37e-04	40	37	2	16210410
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	LARS1 PUM3 HADHA HNRNPU DNMT1	8.54e-04	704	37	5	29955894
Pubmed	Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1.	PARP4 KANK1	8.80e-04	41	37	2	8724849
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	LARS1 HADHA RRBP1	9.16e-04	179	37	3	36261009
Pubmed	Exploring an Alternative Cysteine-Reactive Chemistry to Enable Proteome-Wide PPI Analysis by Cross-Linking Mass Spectrometry.	RRBP1 OXR1 HNRNPU DNMT1	9.33e-04	411	37	4	36652389
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	FEZ2 RBMS3 ZC3H8 MORF4L1 HNRNPU	9.62e-04	723	37	5	34133714
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	LRP2 GIGYF2 ZFHX3 PRDM2	9.93e-04	418	37	4	34709266
Pubmed	Identification of new mechanisms of cellular response to chemotherapy by tracking changes in post-translational modifications by ubiquitin and ubiquitin-like proteins.	PCID2 HNRNPU	1.06e-03	45	37	2	24654937
Pubmed	The telomeric protein AKTIP interacts with A- and B-type lamins and is involved in regulation of cellular senescence.	LARS1 HADHA	1.06e-03	45	37	2	27512140
Interaction	FBP1 interactions	H1-6 GIGYF2 LIMA1 HADHA RRBP1 HNRNPU DNMT1	2.34e-06	348	36	7	int:FBP1
Interaction	H2BC9 interactions	H1-6 GIGYF2 PARP4 USP46 RRBP1 PCLO DNMT1	1.19e-05	446	36	7	int:H2BC9
Interaction	SLC44A4 interactions	RRBP1 HNRNPU	1.86e-05	4	36	2	int:SLC44A4
Interaction	H2AC20 interactions	RNF8 H1-6 PUM3 USP46 MORF4L1 DNMT1	1.99e-05	320	36	6	int:H2AC20
Interaction	H1-1 interactions	H1-6 PUM3 KANK1 ZC3H8 PCLO HNRNPU SCN4A	2.71e-05	507	36	7	int:H1-1
Interaction	BRD1 interactions	LRP2 LIMA1 FEZ2 ZC3H15 PCID2 DNMT1	2.99e-05	344	36	6	int:BRD1
Cytoband	Ensembl 112 genes in cytogenetic band chr9p24	PUM3 KANK1	3.28e-03	105	37	2	chr9p24
GeneFamily	Zinc fingers CCCH-type	ZC3H8 ZC3H15	1.24e-03	35	27	2	73
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	GIGYF2 ZFHX3 LIMA1 RBMS3 MORF4L1 HNRNPU DNMT1	3.53e-06	467	37	7	M1347
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	GIGYF2 ZFHX3 LIMA1 RBMS3 MORF4L1 HNRNPU DNMT1	4.47e-06	484	37	7	MM999
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	GIGYF2 PARP4 OXR1 SLMAP	1.68e-05	186	37	4	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	3'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNF8 HADHA FEZ2 ZSCAN30	1.79e-05	189	37	4	7dad62bd50c197838058e89abd0ee387de3e83cd
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRP2 MYO3A KANK1 OXR1	1.79e-05	189	37	4	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRP2 MYO3A KANK1 OXR1	1.86e-05	191	37	4	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRP2 KANK1 OXR1 PCLO	1.94e-05	193	37	4	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRP2 KANK1 OXR1 PCLO	1.94e-05	193	37	4	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LIMA1 RBMS3 SYTL5	2.91e-04	156	37	3	896e2d958be0a5c62fb6eebad2dfb7e1ce69f3ad
ToppCell	Basal_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	ELOVL4 ANKRD31 RBMS3	3.14e-04	160	37	3	b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRP2 KANK1 OXR1	3.37e-04	164	37	3	382e42701779d12a7948690b3be72d06dd75c8b4
ToppCell	COPD-Lymphoid-ILC_B\|Lymphoid / Disease state, Lineage and Cell class	ZFHX3 USP46 RBMS3	3.49e-04	166	37	3	e2cad1db536d5ad5a34c337c19b5e7d1a2851552
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LRP2 AP1M2 FATE1	3.56e-04	167	37	3	25af48c640e67848594f5902867ba325fc105da4
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	LRP2 AP1M2 PCLO	3.62e-04	168	37	3	e870d2e69316406f45112ed0bf324b24f902a99e
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	LRP2 AP1M2 PCLO	3.62e-04	168	37	3	403aba73a0f9ffb32252288d075fad8a588ca440
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LRP2 MYO3A OXR1	3.62e-04	168	37	3	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LIMA1 RBMS3 SYTL5	3.81e-04	171	37	3	5efd15300f865ebf651e0888265cbd717bc3b9d3
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	LRP2 MYO3A RBMS3	3.88e-04	172	37	3	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	LRP2 AP1M2 PCLO	3.94e-04	173	37	3	e05cddf5bf63cf419343ff229453327519765be8
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	LRP2 AP1M2 PCLO	3.94e-04	173	37	3	3d7c281a1a9f183a5a861d1a9c7b50d216535893
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|367C / Donor, Lineage, Cell class and subclass (all cells)	LRP2 AP1M2 PCLO	3.94e-04	173	37	3	74ad5ed33821b8816c9c8e67c50ee4496ba18e2f
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	LRP2 AP1M2 PCLO	3.94e-04	173	37	3	3aa90578371039f81b7c6fa873ec70f8f2bc7dfa
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ELOVL4 LRP2 PCLO	3.94e-04	173	37	3	66f37c1437705734b20601656fa4aa1d92ca30be
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ELOVL4 LRP2 PCLO	3.94e-04	173	37	3	649b08a409095592cccf31883be69c754411280d
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-skeletal_muscle_satellite_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ELOVL4 LRP2 PCLO	4.01e-04	174	37	3	f230d23618a6487f2664efb2c677e0a4559e2bf4
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	H1-6 MYO3A PCLO	4.15e-04	176	37	3	da5933eb253f13e70296a50a2bb00ad5c19a2d99
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO3A RBMS3 SYTL5	4.22e-04	177	37	3	b75f519d72611b293d9684f7dcfb1b70fbf54a90
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PARP4 KANK1 OXR1	4.29e-04	178	37	3	c20f050344a2e120e685e2a7fe36c6dfc1dc37b6
ToppCell	metastatic_Brain-T/NK_cells-Exhausted_Tfh\|T/NK_cells / Location, Cell class and cell subclass	ZFHX3 LIMA1 OTUD7A	4.29e-04	178	37	3	9a3581a0158dfa5a1cc942f8c532afb5e38b272a
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LRP2 AP1M2 PCLO	4.29e-04	178	37	3	3d120458a0a56097532ebfa5fc6f77b52af2af2a
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LRP2 MYO3A OXR1	4.29e-04	178	37	3	544379f5a6145429762258d426b876bb36c112f5
ToppCell	droplet-Limb_Muscle-Pre-Sort\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 KANK1 MORF4L1	4.43e-04	180	37	3	af2bafcd1b2082629de3ea336711add01565c4c4
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LRP2 OXR1 PCLO	4.43e-04	180	37	3	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 KANK1 MORF4L1	4.43e-04	180	37	3	f29a995cf6e1a1836ed68b73258d9370bf3d4434
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANK1 OXR1 SYTL5	4.57e-04	182	37	3	eb4be1c02b8b033d025e57b8b4cdbfaec4698054
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LRP2 OXR1 PCLO	4.57e-04	182	37	3	9d67717a6e13bcb54c1297a3e4e3abf4e51628a3
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO3A RBMS3 SYTL5	4.65e-04	183	37	3	f8b636391f752e379a5c5575fd898bdf0907a3b8
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO3A RBMS3 SYTL5	4.72e-04	184	37	3	e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO3A RBMS3 SYTL5	4.87e-04	186	37	3	96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO3A RBMS3 SYTL5	4.87e-04	186	37	3	310d16f4e5cffee3ea6d7635508c513a3b92131e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LRP2 KANK1 OXR1	4.87e-04	186	37	3	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRP2 KANK1 OXR1	4.95e-04	187	37	3	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	COVID-19-kidney\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LRP2 OXR1 PCLO	4.95e-04	187	37	3	d23aae9419d460b78b1d4092d7acd9108a47cfbe
ToppCell	droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIMA1 DNMT1 SLMAP	4.95e-04	187	37	3	14c239af77116d28d511dea754b6150d20488080
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO3A RBMS3 SYTL5	5.02e-04	188	37	3	8268574584e5fb869a6cb8bbd7135cd7454a6a25
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	PUM3 KANK1 PCLO	5.02e-04	188	37	3	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO3A RBMS3 SYTL5	5.02e-04	188	37	3	4544552ebd67e9eb3e40d8511bb2b03a6e1178f8
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LRP2 ZFHX3 KANK1	5.10e-04	189	37	3	42ab4cc5fbf8580841f31889446fe4499df1a464
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LRP2 MYO3A KANK1	5.10e-04	189	37	3	28b502611829e4a24caff2562545c7db97686099
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PARP4 KANK1 OXR1	5.10e-04	189	37	3	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LRP2 AP1M2 SYTL5	5.10e-04	189	37	3	c8b8f860aaf6c73863cd79941db6b469c830ef06
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO3A RBMS3 SYTL5	5.10e-04	189	37	3	f0aaf2994d319a39877d2845eaab9f166adead4e
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO3A RBMS3 SYTL5	5.18e-04	190	37	3	56cc761e50fddfb5366391518b4d8e16589b6b42
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LRP2 AP1M2 PCLO	5.18e-04	190	37	3	c95032bb3ee2b3d40fdf48016acb46d6f78a48a6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRP2 KANK1 OXR1	5.18e-04	190	37	3	989d4eefd22d66ecb857836f8fdbcf41e3047f84
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	ZFHX3 MYO3A LIMA1	5.18e-04	190	37	3	842760bfe0a52e67bad800efa7d99448a4a23ebb
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO3A RBMS3 SYTL5	5.18e-04	190	37	3	25d4b591f75c26e404a34c42f1742d580af6598d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PARP4 KANK1 OXR1	5.26e-04	191	37	3	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO3A RBMS3 SYTL5	5.26e-04	191	37	3	fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	LRP2 KANK1 PCLO	5.26e-04	191	37	3	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO3A RBMS3 SYTL5	5.26e-04	191	37	3	7b386512284dfaa0e95358b28ee82632ee965e64
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LRP2 AP1M2 MYO3A	5.34e-04	192	37	3	d3634574b2e8d2ded6446969361b70761b331aea
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	LRP2 KANK1 PCLO	5.34e-04	192	37	3	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFHX3 OXR1 HNRNPU	5.34e-04	192	37	3	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LRP2 AP1M2 MYO3A	5.34e-04	192	37	3	1aa5e4d9b32013a3f272561dcb8377f6805706df
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	LRP2 KANK1 OXR1	5.34e-04	192	37	3	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LRP2 AP1M2 MYO3A	5.42e-04	193	37	3	5f0eba7b1440beb891d94a288f7f18a4e13c3a88
ToppCell	LA\|World / Chamber and Cluster_Paper	LRP2 ZFHX3 RRBP1	5.42e-04	193	37	3	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	LRP2 AP1M2 PCLO	5.42e-04	193	37	3	de569c6e507856fd3ac2311f246cb597074ed30c
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LIMA1 KANK1 DNMT1	5.42e-04	193	37	3	e477f5ddbb9d5878560998250ca0e1a5467953f4
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-J_(Lipofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	LRP2 AP1M2 PCLO	5.51e-04	194	37	3	784b15119c91ace33d34bfb3d68c182566a3e9a8
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PUM3 LIMA1 DNMT1	5.51e-04	194	37	3	40c6e17e9e48d4fa6da3a0a1066c4c6565a1e096
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LRP2 AP1M2 PCLO	5.51e-04	194	37	3	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LRP2 KANK1 OXR1	5.51e-04	194	37	3	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KANK1 OXR1 PCLO	5.51e-04	194	37	3	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KANK1 OXR1 PCLO	5.51e-04	194	37	3	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KANK1 OXR1 PCLO	5.59e-04	195	37	3	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	KANK1 RBMS3 SLMAP	5.59e-04	195	37	3	4dba732c8d8ecf0ed9ece1814dc4060402199ed9
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LRP2 AP1M2 MYO3A	5.59e-04	195	37	3	b78db0d929be6b04055805ea5ffecc56c47ba956
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KANK1 OXR1 PCLO	5.67e-04	196	37	3	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KANK1 OXR1 PCLO	5.67e-04	196	37	3	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	PUM3 RRBP1 DNMT1	5.76e-04	197	37	3	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	(5)_Dendritic_cell-(54)_pDC\|(5)_Dendritic_cell / shred on Cell_type and subtype	FEZ2 RBMS3 ZC3H8	5.84e-04	198	37	3	fc6c6b60dddd7f2f997af0f87fae33f1c23f34a8
ToppCell	Sepsis-ICU-NoSEP-Myeloid-tDC\|ICU-NoSEP / Disease, condition lineage and cell class	PARP4 LIMA1 USP46	5.93e-04	199	37	3	90ddd686b8f39c6f6134b9b048396cebcf8d0448
ToppCell	MS-Multiple_Sclerosis-Myeloid-pDC\|Multiple_Sclerosis / Disease, condition lineage and cell class	RRBP1 FEZ2 RBMS3	5.93e-04	199	37	3	c10c8c9322cad4996e4aa11a8680e3d781644ace
ToppCell	3'-GW_trimst-1.5\|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	OXR1 RBMS3 MORF4L1	5.93e-04	199	37	3	8e69d718ed5b05b08550973c33c92f0c6bfccc68
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	LIMA1 ZC3H15 ZNF706	5.93e-04	199	37	3	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	Sepsis-ICU-NoSEP-Myeloid-pDC\|ICU-NoSEP / Disease, condition lineage and cell class	KANK1 RRBP1 FEZ2	5.93e-04	199	37	3	a199e67438eeed903d0996605591ec54400fdd66
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RRBP1 RBMS3 SYTL5	6.01e-04	200	37	3	a9cdddc4e985dae59521e557479c24fcc2ac727d
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial\|6m / Sample Type, Dataset, Time_group, and Cell type.	LIMA1 RRBP1 RBMS3	6.01e-04	200	37	3	2cc98abf11f5b58707de45a2282f03d47f00f035
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PCDH20-L1-2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KANK1 RBMS3 SYTL5	6.01e-04	200	37	3	1d67c5d2c617749b521e70879950dea2c9d076d6
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ZFHX3 KANK1 SLMAP	6.01e-04	200	37	3	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	LIMA1 RRBP1 PCLO	6.01e-04	200	37	3	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	LIMA1 RRBP1 RBMS3	6.01e-04	200	37	3	0f7431f670f3a175377cefae3479403a881bb8fb
ToppCell	facs-Brain_Non-Myeloid-Hippocampus\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HADHA RRBP1 HNRNPU	6.01e-04	200	37	3	fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HADHA RRBP1 HNRNPU	6.01e-04	200	37	3	f0c338877e39226a90c4effe12f6501d33542a73
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RRBP1 RBMS3 SYTL5	6.01e-04	200	37	3	33b9199e0dfc267e2cea20b82d1c167f8adcc635
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RRBP1 RBMS3 SYTL5	6.01e-04	200	37	3	9719fabddc34051949468a7520289e3c750de4f8
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	MYO3A RBMS3 SYTL5	6.01e-04	200	37	3	d416a7be1a4e6232fb58a9687774da24821f1fdd
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LIMA1 RRBP1 PCLO	6.01e-04	200	37	3	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR\|Neuronal / cells hierarchy compared to all cells using T-Statistic	MYO3A RBMS3 SYTL5	6.01e-04	200	37	3	862db57d043bdf3cb059fbfc8b29bc1eafdf64ec
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ZFHX3 KANK1 SLMAP	6.01e-04	200	37	3	c06426f877919bdd267ea2fd7e7973c6619832ae
Disease	response to methotrexate, drug-induced liver injury	MYO3A RBMS3	4.88e-04	26	37	2	EFO_0004228, GO_0031427
Disease	body surface area	GIGYF2 ZFHX3 FEZ2 SCN4A DNMT1	1.18e-03	643	37	5	EFO_0022196

Protein segments in the cluster

Peptide	Gene	Start	Entry
KAKGQFKKQSVANGV	AP1M2	296	Q9Y6Q5
GKKKKQNKNRISWVG	DNMT1	721	P26358
KFADGGQKKRQNQSK	RBMS3	221	Q6XE24
GKKGVKQFKNKQQGD	PUM3	61	Q15397
KQFKNKQQGDKSPKN	PUM3	66	Q15397
EVKTKKNKQKTPGNG	MORF4L1	146	Q9UBU8
GQKNAKAAQTKLAKG	CFAP99	416	D6REC4
GKQIRKNEQFSGKKE	ANKRD31	456	Q8N7Z5
VENAKASKKNGNVGK	LIMA1	636	Q9UHB6
KQLMIENGKKQKNGK	ELOVL4	296	Q9GZR5
KKQKVVQKEQGKPEG	PCLO	191	Q9Y6V0
GSKKSNKNKSGKNQF	HNRNPU	686	Q00839
KDGNKDSNGAKKNLQ	KANK1	981	Q14678
KGEVWKQNKFGQGKK	LRP2	4291	P98164
KQNKFGQGKKEKTLV	LRP2	4296	P98164
NSNNGKNGKDKEKEK	OTUD7A	486	Q8TE49
QQKKKLQTDIKENGG	PARP4	21	Q9UKK3
EFKQKQSVNKGKQGK	OXR1	476	Q8N573
NADQQLVKKGKSKVG	PCID2	121	Q5JVF3
SGRKAKGAKGKQQQK	H1-6	166	P22492
KGAKGKQQQKSPVKA	H1-6	171	P22492
QQSNFEAVQSGKKKK	GIGYF2	1251	Q6Y7W6
QQQVFKGLNDKVKKK	HADHA	401	P40939
GASQKKQKLEQKAAG	FATE1	46	Q969F0
KKLKNGSSQNGKNER	FEZ2	281	Q9UHY8
GKKKSQENKNKGNKI	PRDM2	171	Q13029
QLQGNKTFKKGKKKE	SYTL5	566	Q8TDW5
DNFNQQKKKLGGKDI	SCN4A	1296	P35499
MNVKKQTQKGNSKKV	RNF8	271	O76064
GFKGQKVQDVKKTIQ	LARS1	481	Q9P2J5
KKQKGNAAGNKISQL	ZSCAN30	236	Q86W11
QNQGKKTEGAQGKKA	RRBP1	516	Q9P2E9
QGKKADAAANQGKKT	RRBP1	586	Q9P2E9
QGANNKKIAKDVFKK	SLC27A4	466	Q6P1M0
GKQEEIQQKGQAEKK	SLMAP	326	Q14BN4
KKQAGQKKKQGHDQK	ZNF706	16	Q9Y5V0
KQEKQNGKLKNGNMN	USP46	141	P62068
QAQAGGSKKAEQKKK	ZC3H15	6	Q8WU90
DKTFGLKNKKGAKQQ	ZC3H15	26	Q8WU90
NENKQKVQKKNGKTD	ZFHX3	1961	Q15911
KVQKKNGKTDQGENL	ZFHX3	1966	Q15911
KQKNKNLKAGHKNGK	ZC3H8	126	Q8N5P1
FKVLNKKNGQKAAVK	MYO3A	36	Q8NEV4